Beth Israel Hosp is a clinical research site located in Boston, Massachusetts, United States 02215.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Beth Israel Hosp has participated in 8 clinical trials.
Therapeutic areas: Cytomegalovirus Infections, HIV Infections, Chickenpox.
Sponsors: Hoffmann-La Roche, National Institute of Allergy and Infectious Diseases (NIAID), Sequus Pharmaceuticals.
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Beth Israel Hosp has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Beth Israel Hosp has 8 clinical trials on record. Their work covers Cytomegalovirus Infections, HIV Infections, Chickenpox.
Yes — Beth Israel Hosp holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.